Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kostas Delaunay

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Nuclear Medicine|October 21, 2016
18F-Choline Uptake in Acute Ischemic StrokeKostas Delaunay, Florence Le Jeune, Etienne Garin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 19, 2026
Comparison of pre-therapeutic [<sup>99m</sup>Tc]Tc-MAA SPECT/CT and post-therapeutic <sup>90</sup>Y-PET/CT dosimetry for outcome prediction in hepatocellular carcinoma treated with resin microspheresKostas Delaunay, Arnaud Dieudonné, Marco Dioguardi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2019
Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with <sup>188</sup>Re-SSS Lipiodol radioembolizationKostas Delaunay, Julien Edeline, Yan Rolland, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Nuclear Medicine|October 21, 2016
18F-Choline Uptake in Acute Ischemic StrokeKostas Delaunay, Florence Le Jeune, Etienne Garin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 19, 2026
Comparison of pre-therapeutic [<sup>99m</sup>Tc]Tc-MAA SPECT/CT and post-therapeutic <sup>90</sup>Y-PET/CT dosimetry for outcome prediction in hepatocellular carcinoma treated with resin microspheresKostas Delaunay, Arnaud Dieudonné, Marco Dioguardi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2019
Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with <sup>188</sup>Re-SSS Lipiodol radioembolizationKostas Delaunay, Julien Edeline, Yan Rolland, et al.
Pageof 1